Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.86 +0.01 (+0.11%)
As of: Oct 22, 2026 · 3:48 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Net Equity Issued and Repurchased (2022 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) reported Net Equity Issued and Repurchased of $9 million for Q2 2026, up 0.5% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aspire Biopharma Holdings' Net Equity Issued and Repurchased came in at $17.95 million; for FY2024, it was $2.5 million.

  • By year, Net Equity Issued and Repurchased came in at $14.65 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q1 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Mar 31, 2026 8.95 Mn
Jun 30, 2024 28,561.00
Mar 31, 2024 229,084.00
Sep 30, 2023 -632,968.00
Mar 31, 2022 297.15 Mn
API Access

Aspire Biopharma Holdings, Inc. Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ASBP&period=max&api_key=YOUR_API_KEY